Table 1.
A presentation of part of the GO and KEGG pathway enrichment analysis for the DEGs associated with cancer genesis and progress
| Category | ID | Term | P-value |
|---|---|---|---|
| BP | GO:0043062 | Regulation of heterotypic cell-cell adhesion | 3.0E-04 |
| BP | GO:0043062 | Extracellular structure organization | 3.0E-04 |
| BP | GO:0006954 | Inflammatory response | 2.9E-03 |
| BP | GO:0019221 | Cytokine-mediated signaling pathway | 5.8E-03 |
| BP | GO:0045595 | Regulation of cell differentiation | 1.3E-02 |
| MF | GO:0004908 | Interleukin-1 receptor activity | 1.1E-03 |
| MF | GO:0070851 | growth factor receptor binding | 2.5E-02 |
| MF | GO:0005102 | Signaling receptor binding | 1.5E-02 |
| MF | GO:0048018 | Receptor ligand activity | 2.4E-02 |
| MF | GO:0070851 | growth factor receptor binding | 2.5E-02 |
| CC | GO:0034358 | Plasma lipoprotein particle | 1.8E-04 |
| CC | GO:0005576 | Extracellular region | 2.3E-04 |
| CC | GO:0071682 | Endocytic vesicle lumen | 8.5E-04 |
| CC | GO:0005788 | Endoplasmic reticulum lumen | 5.2E-03 |
| CC | GO:0005764 | Lysosome | 3.0E-02 |
| KEGG pathway | hsa04512 | ECM-receptor interaction | 9.8E-03 |
| KEGG pathway | hsa04064 | NF-kappa B signaling pathway | 1.0E-02 |
| KEGG pathway | hsa04620 | Toll-like receptor signaling pathway | 1.0E-02 |
| KEGG pathway | hsa04060 | Cytokine-cytokine receptor interaction | 3.7E-02 |
| KEGG pathway | hsa04010 | MAPK signaling pathway | 4.5E-02 |